Back to Search
MARK BENYUNES, M.D.
M.D.
Medical Oncology Physician
NPI: 1538418298Individual
Specialties, Licenses & Credentials
Research & Publications (9)
Rituximab in combination with fludarabine chemotherapy in low-grade or follicular lymphoma.
PMID 15681517·J Clin Oncol·2005
3-trial
Recombinant human thrombopoietin augments mobilization of peripheral blood progenitor cells for autologous transplantation.
PMID 12813449·Biol Blood Marrow Transplant·2003
3-trial
Use of thrombopoietin in combination with chemotherapy and granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization.
PMID 12434950·Biol Blood Marrow Transplant·2002
3-trial
Rituximab in combination with CHOP or fludarabine in low-grade lymphoma.
PMID 11842387·Semin Oncol·2002
6-review
Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: results of a multicenter randomized controlled trial.
PMID 11533101·J Clin Oncol·2001
3-trial
Recombinant human thrombopoietin (rhTPO) after autologous bone marrow transplantation: a phase I pharmacokinetic and pharmacodynamic study.
PMID 11277173·Bone Marrow Transplant·2001
3-trial
Optimizing the use of rituximab for treatment of B-cell non-Hodgkin's lymphoma: a benefit-risk update.
PMID 11226001·Semin Oncol·2000
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 1 DNA WAY, MAILSTOP 444B
SOUTH SAN FRANCISCO, CA 94080 - Phone
- (650) 225-1628
Quick Facts
- NPI
- 1538418298
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 9
Are you this provider?
Claim Your Profile